查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1877442

分子胶降解剂市场：按类型、给药方式、最终用户、应用、国家和地区划分－全球产业分析、市场规模、市场份额及2025-2032年预测

Molecular Glue Degradation Agent Market, By Type, By Delivery Method, By End User, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年分子胶降解剂市场规模为 4.02 亿美元，2025 年至 2032 年复合年增长率为 8.6%。

分子胶降解剂市场是标靶蛋白降解 (TPD) 疗法的新兴领域，该疗法利用分子胶——一种能诱导目标蛋白与 E3 泛素连接酶接近的小分子——来实现选择性蛋白质降解。分子胶降解剂市场正快速扩张，其驱动力在于对能够降解以往「不可成药」蛋白的疗法的需求日益增长，尤其是在肿瘤学和罕见疾病领域。一个主要的市场趋势是人工智慧平台和基于结构的药物设计工具的快速应用，这加速了新型分子胶降解剂的发现。然而，阻碍商业化进程的一大挑战是监管政策不明朗，以及早期研发阶段难以预测标靶选择性和脱靶效应。儘管如此，分子胶的应用前景依然广阔，可望拓展至癌症以外的神经退化性疾病、发炎性疾病和代谢性疾病等领域，在这些领域，标靶蛋白降解可望带来首创的治疗突破。

分子胶降解剂市场－市场动态

对永续製造日益增长的需求推动市场成长

随着製药公司将环境友善药物研发置于优先地位，对永续生产的需求日益增长，这成为分子胶降解剂市场的重要成长驱动力。分子胶能够利用小而高效的分子进行标靶蛋白质降解，进而助力实现永续发展目标。与传统方法相比，分子胶所需的原料较少，合成步骤较简单，产生的化学废弃物也较少。随着全球减少製药生产环境足迹的压力不断增大，製造商正在加速采用更环保的化学技术和节能的研发平台。策略性的产业合作也进一步强化了这个趋势。例如，2024年5月，武田製药与Degron Therapeutics签署了一项价值高达12亿美元的授权协议，共同开发可扩展的分子胶降解剂，这反映了市场正朝着更永续、资源更高效的治疗方案转变。预计这一永续发展趋势将在未来几年推动市场成长。

分子胶降解剂市场区隔分析：

全球市场按类型、交付方式、最终用户、应用程式和地区进行细分。

基于终端用户细分，製药公司是全球分子胶降解剂市场中最重要的类别之一，因为它们推动了新型标靶疗法的临床开发和商业化。分子胶，例如 PROTAC 和 LYTAC，因其选择性降解致病蛋白的能力而受到越来越多的研究，使其成为新型药物研发管线的理想选择。例如，2024 年 12 月，Monte Rosa Therapeutics 公司报告称，其 MRT-2359 I/II 期临床试验的剂量递增阶段显示，在接受过大量预处理的实体瘤患者中，采用 21 天用药、7 天停药的给药方案，该药物具有良好的安全性，并能有效降解 GSPT1。预计将于 2025 年第一季公布更多临床资料，包括生物标记和活性讯息，凸显了製药和生物技术产业在靶向蛋白降解方面取得的持续进展。

根据类型划分，蛋白水解靶向嵌合体（PROTAC样）是分子胶降解剂市场的重要组成部分，因为它能够选择性地募集E3泛素连接酶来降解致病蛋白，从而为以往「不可成药」的靶点提供了一种强有力的解决方案。业界活跃的研发活动，例如Monte Rosa Therapeutics在分子胶降解剂领域的进展，凸显了其重要性。 2025年4月，该公司公布了临床前资料，证明其CDK2标靶降解剂MRT-51443与现有疗法联合使用时，能够改善HR阳性/HER2阴性乳癌模型中的肿瘤消退。 Monte Rosa在2025年的产品线更新中也重点介绍了即将提交的IND申请，包括用于降解NEK7的MRT-8102以及实体瘤候选药物MRT-2359的持续研发。 Monte Rosa于2024年底与诺华达成重大合作，其中包括1.5亿美元的首付款以及超过20亿美元的潜在里程碑付款，用于其VAV1靶向胶水降解剂的研发，这凸显了该细分市场的商业价值。这些进展共同表明，PROTAC类细分市场是分子胶水降解生态系统中高价值的成长引擎。

分子胶降解剂市场—地域性洞察

北美市场以对生物技术和製药研发的大量投资为特征，这得益于其完善的基础设施以及众多领先的研究机构和公司。同时，中东和非洲市场呈现多元化格局，医疗保健体系的改善和生命科学领域的投资推动了市场成长。拉丁美洲市场也在逐步扩张，对生物製药开发和合作的兴趣日益浓厚，为生物技术进步创造了有利环境。地域划分凸显了不同地区在成熟度、投资水准和监管环境方面的差异，这些因素对分子胶降解剂的全球市场动态产生了重大影响。

美国分子胶降解剂市场—国家概况

美国凭藉其强大的生物技术生态系统、先进的研究基础设施以及对新一代标靶蛋白降解技术的快速应用，成为北美分子胶降解剂市场最重要的国家。美国拥有众多领先的製药创新者、顶尖的学术研究机构以及密集的临床试验中心网络，这使得分子胶概念能够更快地转化为临床阶段的治疗药物。此外，美国受益于FDA对突破性疗法的支持性审批途径和强劲的风险投资，这两方面都加速了市场扩张。这种领先地位体现在许多发展案例中，例如艾伯维（AbbVie）于2025年1月与Neomorph的合作，后者获得了高达16.4亿美元的资金，用于推进分子胶降解剂在肿瘤学和免疫学领域的应用——这表明美国主导的合作和资金投入正在塑造分子胶技术的全球发展轨迹。

分子胶降解剂市场－竞争格局：

分子胶降解剂市场竞争异常激烈，其发展主要受标靶蛋白降解技术的创新和策略合作的推动。作为PROTAC和分子胶技术的先驱，Arvinas已将多个候选药物推进至肿瘤及其他领域的临床试验阶段。 Kymera Therapeutics以其专有的E3连接酶靶向平台以及与吉利德和其他製药公司在开发新型分子胶方面开展的卓有成效的合作而闻名。 C4 Therapeutics也利用其整合的BiDAC和MonoDAC平台加速分子胶降解剂的发现和临床开发。这些公司以及AbbVie和Genentech等其他创新企业，正透过技术领先、产品线推进和策略联盟重塑市场竞争格局，使其处于这个快速变化的市场的前沿。

目录

第一章：分子胶降解剂市场概述

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
    • 分子胶降解剂市场概览（按类型划分）
    • 分子胶降解剂市场概况（依给药方式划分）
    • 分子胶降解剂市场按最终用户分類的概况
    • 分子胶降解剂市场按应用领域分類的概况
    • 各国分子胶降解剂市场概况
    • 分子胶降解剂市场区域概览
  • 竞争洞察

第三章：分子胶降解剂市场主要趋势

  • 分子胶降解剂市场驱动因素
    • 市场驱动因素的影响分析
  • 分子胶降解剂市场限制因素
    • 市场限制因素的影响分析
  • 分子胶降解剂市场机会
  • 分子胶降解剂市场未来趋势

第四章：分子胶降解剂产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：分子胶降解剂市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：分子胶降解剂市场概况

  • 分子胶降解剂市占率分析，2024年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：分子胶降解剂市场－按类型划分

  • 概述
    • 按类型分類的细分市场占有率分析
    • 溶小体靶向嵌合体
    • 蛋白水解靶向嵌合体
    • 其他的

第八章：分子胶降解剂市场－依给药方式划分

  • 概述
    • 按交付方式分類的细分市场份额分析
    • 口服
    • 注射剂

第九章：分子胶降解剂市场－以最终用户划分

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 学术和研究机构
    • 生技公司

第十章：分子胶降解剂市场－依应用领域划分

  • 概述
    • 按交付方式分類的细分市场份额分析
    • 消费性电子产品
    • 汽车
    • 电信和数据通信
    • 能源与电力
    • 工业的
    • 其他的

第十一章：分子胶降解剂市场－依地域划分

  • 介绍
    • 按地域分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美分子胶降解剂主要生产商
    • 北美市场规模及预测（按国家/地区划分）
    • 北美市场规模及预测（按类型划分）
    • 北美市场规模及预测（以交付方式划分）
    • 北美市场规模及预测（依最终用户划分）
    • 北美市场规模及预测（按应用划分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲分子胶降解剂主要生产商
    • 欧洲市场规模及预测（按国家/地区划分）
    • 欧洲市场规模及预测（按类型划分）
    • 欧洲市场规模及预测（以交付方式划分）
    • 欧洲市场规模及预测（依最终用户划分）
    • 欧洲市场规模及预测（按应用领域划分）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区
    • 概述
    • 亚太地区分子胶降解剂主要生产商
    • 亚太市场规模及预测（依国家/地区划分）
    • 亚太市场规模及预测（按类型划分）
    • 亚太市场规模及预测（以交付方式划分）
    • 亚太市场规模及预测（依最终用户划分）
    • 亚太市场规模及预测（按应用划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲分子胶降解剂主要生产商
    • 拉丁美洲市场规模及预测（按国家/地区划分）
    • 拉丁美洲市场规模及预测（按类型划分）
    • 拉丁美洲市场规模及预测（以交付方式划分）
    • 拉丁美洲市场规模及预测（按最终用户划分）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲分子胶降解剂主要生产商
    • MEA市场规模及预测（依国家/地区划分）
    • MEA市场规模及预测（按类型划分）
    • 中东和非洲市场规模及预测（以交付方式划分）
    • MEA市场规模及预测（依最终用户划分）
    • MEA市场规模及预测（依应用划分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 中东和非洲其他地区

第十二章：主要供应商分析－分子胶降解剂产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Arvinas
    • Jiangsu Chia Tai-Tianqing
    • Nanjing Shunxin
    • C4 Therapeutics
    • AbbVie
    • Venquis Therapeutics
    • Monte Rosa Therapeutics
    • Qilu Pharmaceutical
    • Kymera Therapeutics
    • Genentech (Roche)
    • Takeda Pharmaceuticals
    • Eli Lilly and Company
    • Bristol-Myers Squibb
    • Pfizer
    • Gilead Sciences
    • Hansoh
    • Beijing SL
    • Yangtze River

第十三章：360度AnalystView

第十四章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5753

The Molecular Glue Degradation Agent Market size was valued at US$ 402 Million in 2024, expanding at a CAGR 8.6% from 2025 to 2032.

The Molecular Glue Degradation Agent Market is an emerging segment of targeted protein degradation (TPD) therapies that use molecular glues-small molecules that induce proximity between a target protein and an E3 ubiquitin ligase, resulting in selective protein degradation. The Molecular Glue Degradation Agent Market is expanding rapidly, driven by the growing demand for therapies capable of degrading previously "undruggable" proteins, particularly in oncology and rare diseases. A major market trend is the rapid adoption of AI-enabled platforms and structure-based design tools, which accelerate the discovery of novel molecular glue degraders. However, a significant challenge to faster commercial progress is a lack of regulatory clarity, as well as the difficulty of predicting target selectivity and off-target effects in early development. Despite this, there is a significant opportunity to expand molecular glue applications beyond cancer to include neurodegenerative, inflammatory, and metabolic disorders, where targeted protein degradation could lead to first-in-class therapeutic breakthroughs.

Molecular Glue Degradation Agent Market- Market Dynamics

Growing Demand for Sustainable Manufacturing Propels Market Growth

The rising demand for sustainable manufacturing is a significant growth driver in the Molecular Glue Degradation Agent market, as pharmaceutical companies prioritize environmentally responsible drug development. Molecular glues contribute to sustainability goals by allowing for targeted protein degradation using small, efficient molecules that require fewer raw materials, have simpler synthesis steps, and produce less chemical waste than traditional approaches. As global pressure grows to reduce pharmaceutical production's environmental footprint, manufacturers are accelerating the use of greener chemistry and energy-efficient development platforms. Strategic industry collaborations help to reinforce this trend. For instance, in May 2024, Takeda Pharmaceuticals signed a licensing agreement with Degron Therapeutics worth up to USD 1.2 billion to develop scalable molecular glue degraders, reflecting the market's shift toward more sustainable and resource-efficient therapeutic solutions. This sustainable trend is expected to drive market growth in the coming years.

Molecular Glue Degradation Agent Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Type, Delivery Method, End User, Application, and Region.

Based End-User segmentation, the pharmaceutical company's segment is one of the most important categories in the Global Molecular Glue Degradation Agent Market because they drive clinical development and commercialization of new targeted therapies. Molecular glues, such as PROTACs and LYTACs, are increasingly being studied for their ability to selectively degrade disease-causing proteins, making them ideal for novel drug pipelines. For instance, In December 2024, Monte Rosa Therapeutics reported that the dose-escalation phase of its Phase I/II trial of MRT-2359 demonstrated a favorable safety profile and effective GSPT1 degradation using a 21-day-on, 7-day-off dosing regimen in heavily pretreated solid tumor patients. Further clinical data, including biomarker and activity insights, are expected in Q1 2025, highlighting ongoing progress in targeted protein degradation in the pharmaceutical and biotechnology industries.

Based on Type segment, The Proteolytic Targeting Chimeras (PROTAC-like) segment is an important component in the Molecular Glue Degradation Agent Market because it allows for the selective recruitment of E3 ubiquitin ligases to degrade pathogenic proteins, providing a powerful solution for previously "undruggable" targets. Its significance is underscored by robust industry activity, such as Monte Rosa Therapeutics' advances in molecular glue degraders. In April 2025, the company presented preclinical data demonstrating that its CDK2-directed degrader MRT-51443 improved tumor regression in HR-positive/HER2-negative breast cancer models when combined with existing therapies. Monte Rosa's 2025 pipeline update also highlighted upcoming IND submissions, including MRT-8102 for NEK7 degradation and the continued development of solid-tumor candidate MRT-2359. Monte Rosa's major partnership with Novartis in late 2024, which included a $150 million upfront payment and potential milestones exceeding $2 billion for its VAV1-targeted glue degraders, underscores the segment's commercial relevance. These developments collectively highlight the PROTAC-like segment as a high-value growth engine in the molecular glue degradation ecosystem.

Molecular Glue Degradation Agent Market- Geographical Insights

North America's market is distinguished by significant investments in biotechnology and pharmaceutical research, which are supported by a robust infrastructure and a concentration of leading research institutions and companies. Meanwhile, the Middle East and Africa offer a diverse market landscape, with growth opportunities driven by improved healthcare systems and investments in life sciences. Finally, Latin America is gradually expanding, with increased interest in biopharmaceutical development and collaborations creating an enabling environment for biotechnology advancement. The geographical segmentation highlights varying degrees of maturation, investment, and regulatory environments, which have a significant impact on global market dynamics for molecular glue degradation agents.

United States Molecular Glue Degradation Agent Market- Country Insights

The United States is the most important country in the North American Molecular Glue Degradation Agent Market due to its robust biotech ecosystem, advanced research infrastructure, and rapid adoption of next-generation targeted protein degradation technologies. The country is home to leading pharmaceutical innovators, top academic research institutions, and a dense network of clinical trial sites, allowing for faster translation of molecular glue concepts into clinical-stage therapeutics. Furthermore, the United States benefits from supportive FDA pathways for breakthrough therapies and robust venture capital investment, both of which accelerate market expansion. This leadership is evident in developments such as AbbVie's January 2025 collaboration with Neomorph, in which the biotech received up to USD 1.64 billion to advance molecular glue degraders in oncology and immunology-demonstrating how U.S.-led partnerships and funding commitments are shaping the global trajectory of molecular glue technologies.

Molecular Glue Degradation Agent Market- Competitive Landscape:

The Molecular Glue Degradation Agent market is highly competitive, driven by innovation in targeted protein degradation and strategic collaborations. Arvinas, a pioneer in PROTAC and molecular glue technologies, has advanced multiple candidates to clinical trials in oncology and other areas. Kymera Therapeutics is well-known for its proprietary E3 ligase-targeting platforms and lucrative collaborations with Gilead and other pharmaceutical companies to develop novel molecular glues. C4 Therapeutics also uses its integrated BiDAC and MonoDAC platforms to accelerate the discovery and clinical development of molecular glue degraders. These companies, along with other innovators such as AbbVie and Genentech, are shaping the competitive landscape through technological leadership, pipeline advancement, and strategic alliances, putting them at the forefront of this rapidly changing market.

Recent Developments:

In March 2025, Magnet Biomedicine has formed a collaboration and licensing agreement with Eli Lilly to identify, develop, and market oncology-focused molecular glue therapies.

In January 2025, AbbVie and Neomorph, Inc. announced a collaboration and licensing agreement to develop novel molecular glue degraders for oncology and immunology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Arvinas
  • Jiangsu Chia Tai-Tianqing
  • Nanjing Shunxin
  • C4 Therapeutics
  • AbbVie
  • Venquis Therapeutics
  • Monte Rosa Therapeutics
  • Qilu Pharmaceutical
  • Kymera Therapeutics
  • Genentech (Roche)
  • Takeda Pharmaceuticals
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Pfizer
  • Gilead Sciences
  • Hansoh
  • Beijing SL
  • Yangtze River

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lysosome Targeting Chimeras
  • Proteolytic Targeting Chimeras
  • Others

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Academic and Research Institutions
  • Biotechnology Firms

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Consumer Electronics
  • Automotive
  • Telecom & Datacom
  • Energy & Power
  • Industrial
  • Others

GLOBAL MOLECULAR GLUE DEGRADATION AGENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Molecular Glue Degradation Agent Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Glue Degradation Agent Market Snippet by Type
    • 2.1.2. Molecular Glue Degradation Agent Market Snippet by Delivery Method
    • 2.1.3. Molecular Glue Degradation Agent Market Snippet by End User
    • 2.1.4. Molecular Glue Degradation Agent Market Snippet by Application
    • 2.1.5. Molecular Glue Degradation Agent Market Snippet by Country
    • 2.1.6. Molecular Glue Degradation Agent Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Glue Degradation Agent Key Market Trends

  • 3.1. Molecular Glue Degradation Agent Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Glue Degradation Agent Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Glue Degradation Agent Market Opportunities
  • 3.4. Molecular Glue Degradation Agent Market Future Trends

4. Molecular Glue Degradation Agent Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Glue Degradation Agent Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Glue Degradation Agent Market Landscape

  • 6.1. Molecular Glue Degradation Agent Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Glue Degradation Agent Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Lysosome Targeting Chimeras
    • 7.1.3. Proteolytic Targeting Chimeras
    • 7.1.4. Others

8. Molecular Glue Degradation Agent Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable

9. Molecular Glue Degradation Agent Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Academic and Research Institutions
    • 9.1.4. Biotechnology Firms

10. Molecular Glue Degradation Agent Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Delivery Method, 2024 & 2032 (%)
    • 10.1.2. Consumer Electronics
    • 10.1.3. Automotive
    • 10.1.4. Telecom & Datacom
    • 10.1.5. Energy & Power
    • 10.1.6. Industrial
    • 10.1.7. Others

11. Molecular Glue Degradation Agent Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Molecular Glue Degradation Agent Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Molecular Glue Degradation Agent Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Molecular Glue Degradation Agent Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Molecular Glue Degradation Agent Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Molecular Glue Degradation Agent Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Molecular Glue Degradation Agent Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Arvinas
    • 12.2.2. Jiangsu Chia Tai-Tianqing
    • 12.2.3. Nanjing Shunxin
    • 12.2.4. C4 Therapeutics
    • 12.2.5. AbbVie
    • 12.2.6. Venquis Therapeutics
    • 12.2.7. Monte Rosa Therapeutics
    • 12.2.8. Qilu Pharmaceutical
    • 12.2.9. Kymera Therapeutics
    • 12.2.10. Genentech (Roche)
    • 12.2.11. Takeda Pharmaceuticals
    • 12.2.12. Eli Lilly and Company
    • 12.2.13. Bristol-Myers Squibb
    • 12.2.14. Pfizer
    • 12.2.15. Gilead Sciences
    • 12.2.16. Hansoh
    • 12.2.17. Beijing SL
    • 12.2.18. Yangtze River

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us